Ashraf S. Ibrahim
Los Angeles Biomedical Research Institute
Division of Infectious Diseases
Harbor-UCLA Medical Center
1124 West Carson St.
USA
Name/email consistency: high
- Combination therapy of murine mucormycosis or aspergillosis with iron chelation, polyenes, and echinocandins. Ibrahim, A.S., Gebremariam, T., Luo, G., Fu, Y., French, S.W., Edwards, J.E., Spellberg, B. Antimicrob. Agents Chemother. (2011)
- The high affinity iron permease is a key virulence factor required for Rhizopus oryzae pathogenesis. Ibrahim, A.S., Gebremariam, T., Lin, L., Luo, G., Husseiny, M.I., Skory, C.D., Fu, Y., French, S.W., Edwards, J.E., Spellberg, B. Mol. Microbiol. (2010)
- The iron chelator deferasirox enhances liposomal amphotericin B efficacy in treating murine invasive pulmonary aspergillosis. Ibrahim, A.S., Gebremariam, T., French, S.W., Edwards, J.E., Spellberg, B. J. Antimicrob. Chemother. (2010)
- Posaconazole mono- or combination therapy for treatment of murine zygomycosis. Ibrahim, A.S., Gebremariam, T., Schwartz, J.A., Edwards, J.E., Spellberg, B. Antimicrob. Agents Chemother. (2009)
- Economic burden of mucormycosis in the United States: can a vaccine be cost-effective?. Ibrahim, A.S., Edwards, J.E., Bryant, R., Spellberg, B. Med. Mycol. (2009)
- Comparison of lipid amphotericin B preparations in treating murine zygomycosis. Ibrahim, A.S., Gebremariam, T., Husseiny, M.I., Stevens, D.A., Fu, Y., Edwards, J.E., Spellberg, B. Antimicrob. Agents Chemother. (2008)
- Iron acquisition: a novel perspective on mucormycosis pathogenesis and treatment. Ibrahim, A.S., Spellberg, B., Edwards, J. Curr. Opin. Infect. Dis. (2008)
- Bacterial endosymbiosis is widely present among zygomycetes but does not contribute to the pathogenesis of mucormycosis. Ibrahim, A.S., Gebremariam, T., Liu, M., Chamilos, G., Kontoyiannis, D., Mink, R., Kwon-Chung, K.J., Fu, Y., Skory, C.D., Edwards, J.E., Spellberg, B. J. Infect. Dis. (2008)
- Combination echinocandin-polyene treatment of murine mucormycosis. Ibrahim, A.S., Gebremariam, T., Fu, Y., Edwards, J.E., Spellberg, B. Antimicrob. Agents Chemother. (2008)
- The iron chelator deferasirox protects mice from mucormycosis through iron starvation. Ibrahim, A.S., Gebermariam, T., Fu, Y., Lin, L., Husseiny, M.I., French, S.W., Schwartz, J., Skory, C.D., Edwards, J.E., Spellberg, B.J. J. Clin. Invest. (2007)
- The anti-Candida vaccine based on the recombinant N-terminal domain of Als1p is broadly active against disseminated candidiasis. Ibrahim, A.S., Spellberg, B.J., Avanesian, V., Fu, Y., Edwards, J.E. Infect. Immun. (2006)
- Deferiprone iron chelation as a novel therapy for experimental mucormycosis. Ibrahim, A.S., Edwards, J.E., Fu, Y., Spellberg, B. J. Antimicrob. Chemother. (2006)
- Rhizopus oryzae adheres to, is phagocytosed by, and damages endothelial cells in vitro. Ibrahim, A.S., Spellberg, B., Avanessian, V., Fu, Y., Edwards, J.E. Infect. Immun. (2005)
- Vaccination with recombinant N-terminal domain of Als1p improves survival during murine disseminated candidiasis by enhancing cell-mediated, not humoral, immunity. Ibrahim, A.S., Spellberg, B.J., Avenissian, V., Fu, Y., Filler, S.G., Edwards, J.E. Infect. Immun. (2005)
- Caspofungin inhibits Rhizopus oryzae 1,3-beta-D-glucan synthase, lowers burden in brain measured by quantitative PCR, and improves survival at a low but not a high dose during murine disseminated zygomycosis. Ibrahim, A.S., Bowman, J.C., Avanessian, V., Brown, K., Spellberg, B., Edwards, J.E., Douglas, C.M. Antimicrob. Agents Chemother. (2005)